Vir Biotechnology Inc VIR:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
after hours iconAfter Hours: Last | 10/15/21 EDT
39.09UNCH (UNCH)
Volume
10,937
Close
39.09quote price arrow down-1.14 (-2.83%)
Volume
899,793
52 week range
25.31 - 141.01
Loading...
  • Open40.22
  • Day High41.46
  • Day Low38.95
  • Prev Close40.23
  • 52 Week High141.01
  • 52 Week High Date01/27/21
  • 52 Week Low25.31
  • 52 Week Low Date01/04/21

Key Stats

  • Market Cap5.106B
  • Shares Out130.61M
  • 10 Day Average Volume1.20M
  • Dividend-
  • Dividend Yield-
  • Beta-
  • YTD % Change45.97

KEY STATS

  • Open40.22
  • Day High41.46
  • Day Low38.95
  • Prev Close40.23
  • 52 Week High141.01
  • 52 Week High Date01/27/21
  • 52 Week Low25.31
  • 52 Week Low Date01/04/21
  • Market Cap5.106B
  • Shares Out130.61M
  • 10 Day Average Volume1.20M
  • Dividend-
  • Dividend Yield-
  • Beta-
  • YTD % Change45.97

RATIOS/PROFITABILITY

  • EPS (TTM)-2.34
  • P/E (TTM)-16.68
  • Fwd P/E (NTM)-43.58
  • EBITDA (TTM)-288.031M
  • ROE (TTM)-45.71%
  • Revenue (TTM)182.71M
  • Gross Margin (TTM)97.37%
  • Net Margin (TTM)-162.74%
  • Debt To Equity (MRQ)0.00%

EVENTS

  • Earnings Date11/08/2021
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Vir Biotechnology Inc

There is no recent news for this security.

Content From Our Affiliates

There is no recent news for this security.

Profile

MORE
Vir Biotechnology, Inc. is a clinical-stage immunology company focused on treating and preventing serious infectious diseases. It has four technology platforms, focused on antibodies, T cells, innate immunity, and small interfering ribonucleic acid (siRNA), through internal development, collaborations, and acquisitions. Its development pipeline consists of product candidates targeting the coronavirus disease 2019 (COVID-19), hepatitis B virus (HBV), influenza A virus and...
Vicki Sato Ph.D.
Non-Executive Chairman
George Scangos Ph.D.
President
Howard Horn
Chief Financial Officer
Ann Hanly
Chief Technology Officer
Herbert Virgin M.D., Ph.D.
Executive Vice President
Address
499 Illinois St Ste 500
San Francisco, CA
94158-2521
United States

Top Peers

SYMBOLLASTCHG%CHG
TWST
Twist Bioscience Corp
112.80-1.69-1.48%
ADPT
Adaptive Biotechnologies Corp
33.50+0.11+0.33%
PACB
Pacific Biosciences of California Inc
24.39-0.16-0.65%
FATE
Fate Therapeutics Inc
61.24-1.27-2.03%
AVIR
Atea Pharmaceuticals Inc
39.28-1.17-2.89%